Analysis of EphA2 expression and mutant p53 in ovarian carcinoma.

Merritt, William M; Thaker, Premal H; Landen, Charles N; Deavers, Michael T; Fletcher, Mavis S; Lin, Yvonne G; Han, Liz Y; Kamat, Aparna A; Schmandt, Rosemarie; Gershenson, David M; Kinch, Michael S; Sood, Anil K

Merritt, William M; Thaker, Premal H; Landen, Charles N; Deavers, Michael T; Fletcher, Mavis S; Lin, Yvonne G; Han, Liz Y; Kamat, Aparna A; Schmandt, Rosemarie; Gershenson, David M; Kinch, Michael S; Sood, Anil K.

Affiliation

Merritt WM; Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77230-1439, USA.

Cancer Biol Ther ; 5(10): 1357-60, 2006 Oct.

Article in En | MEDLINE | ID: mdl-16969087

Subject(s)

Gene Expression Regulation, Neoplastic; Mutation; Ovarian Neoplasms/genetics; Receptor, EphA2/genetics; Tumor Suppressor Protein p53/genetics; Cell Line, Tumor; Exons; Female; Humans; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Gene Expression Regulation, Neoplastic / Tumor Suppressor Protein p53 / Receptor, EphA2 / Mutation Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Cancer Biol Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2006 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links